Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 9:08 PM
Ignite Modification Date: 2025-12-25 @ 6:59 PM
NCT ID: NCT02067104
Description: None
Frequency Threshold: 0
Time Frame: None
Study: NCT02067104
Study Brief: Vismodegib in Basal Cell Carcinomas (BCC) Chemoprevention
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Placebo receive 150 mg of oral placebo daily for a period of 2 months Placebo: Pulse therapy pattern of 2 months of daily treatment and 2 months of no treatment for 24 months. 0 None 0 4 4 4 View
Vismodegib receive 150 mg of vismodegib daily for a period of 2 months Vismodegib: Pulse therapy pattern of 2 months of daily treatment and 2 months of no treatment for 24 months. 0 None 0 5 5 5 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Scale in ear NON_SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
Taste disturbance NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
Leg cramps NON_SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders None View